Cite
HARVARD Citation
Tanaka, E. et al. (2013). AB0308 Optimal timing for tocilizumab administration to patients with rheumatoid arthritis in japan based on a cost-effectiveness analysis using the iorra cohort study. Annals of the rheumatic diseases. p. A881. [Online].